B. Joffe et al., THYROID-ASSOCIATED OPHTHALMOPATHY IN BLACK SOUTH-AFRICAN PATIENTS WITH GRAVES-DISEASE - RELATIONSHIP TO ANTIFLAVOPROTEIN ANTIBODIES, Thyroid, 8(11), 1998, pp. 1023-1027
Thyroid-associated ophthalmopathy (TAO) is a progressive eye disorder
associated with Graves' hyperthyroidism, which is generally considered
to have an autoimmune etiology. Eye muscle membrane proteins of 64 kd
are good markers of ophthalmopathy in patients with thyroid autoimmun
ity, The 64-kd protein is now shown from a partial sequence to be the
flavoprotein subunit (Fp) of mitochondrial succinate dehydrogenase. Hy
perthyroidism due to Graves' disease is increasing in incidence among
urban black female Africans, possibly because of exposure to environme
ntal risk factors such as increased dietary iodine ingestion and stres
s. Ophthalmopathy is frequently observed in this clinical context, but
its association with serum autoantibodies reactive with Fp has not be
en examined. We studied 19 black South African patients with Graves' d
isease during the course of prolonged antithyroid drug administration,
of whom 10 had congestive ophthalmopathy, but no clinical evidence fo
r eye muscle damage at the onset. Anti-Fp antibodies were detected in
2 of these patients, as well as in 2 of the 9 patients who did not hav
e overt eye disease. Additionally, the antibodies became positive in 3
patients with ophthalmopathy in whom tests were negative initially, r
emained positive in 1 patient throughout the study period and became n
egative in 1 patient with positive tests initially. Ophthalmopathy did
not develop in any of the 9 patients who lacked this complication on
presentation. The reasons why we failed to demonstrate a close relatio
nship between anti-Fp antibodies and the eye muscle component of ophth
almopathy are unclear although one possibility is that ocular myopathy
is an uncommon manifestation in African thyrotoxic patients compared
with those of Caucasian origin. The relationship between anti-Fp antib
odies and eye muscle inflammation in patients with thyroid autoimmunit
y of different ethnic origins and environmental settings, needs to be
addressed in a large prospective study.